Literature DB >> 1733267

Studies in vivo and in vitro on effects of PGE2 on colonic motility in rabbits.

R Burakoff1, W H Percy.   

Abstract

Prostaglandins (PG) of the E series are synthesized throughout the gastrointestinal tract, and their elevated levels have been reported in many diarrheal states, including inflammatory bowel disease. It is already known that PGE2 has region-specific and muscle layer-specific effects in different areas of the intestine. The aim of this study was to evaluate possible dose-related motor effects of PGE2 on rabbit proximal and distal colon both in vivo and in vitro. We found that, in the proximal colon in vivo, PGE2 caused inhibition of myoelectric and mechanical activity at low doses but at higher doses caused marked excitation. Under the same experimental conditions, PGE2 caused only excitation in the distal colon, a phenomenon associated with an increase in antegrade contractions and diarrhea. In vitro, PGE2 caused excitation of both proximal and distal colonic longitudinal muscle and relaxation of the circular muscle. Its actions, however, were much more pronounced in the distal region. It is concluded that PGE2 has profound effects on colonic motility that are concentration dependent and that differ with the region of the colon under study. Furthermore, the evidence also suggests that elevated PGE2 levels in disease states may play a significant role in abnormal colonic motility and may facilitate the onset of diarrhea.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733267     DOI: 10.1152/ajpgi.1992.262.1.G23

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Authors:  Liying Dai; Denis W King; D Shevy Perera; David Z Lubowski; Elizabeth Burcher; Lu Liu
Journal:  Dig Dis Sci       Date:  2015-02-11       Impact factor: 3.199

2.  Role of PGE2 in the colonic motility: PGE2 generates and enhances spontaneous contractions of longitudinal smooth muscle in the rat colon.

Authors:  Yumiko Iizuka; Atsukazu Kuwahara; Shin-Ichiro Karaki
Journal:  J Physiol Sci       Date:  2013-10-30       Impact factor: 2.781

3.  Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.

Authors:  E Kankuri; K Vaali; R Korpela; I Paakkari; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

4.  Severe hyperprostaglandin E syndrome with hyperthyroidism--studies of pathogenetic mechanisms.

Authors:  V Fellman; H Pihko; A Majander; H W Seyberth
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  TRPA1-expressing lamina propria mesenchymal cells regulate colonic motility.

Authors:  Yanjing Yang; Shenglan Wang; Kimiko Kobayashi; Yongbiao Hao; Hirosato Kanda; Takashi Kondo; Yoko Kogure; Hiroki Yamanaka; Satoshi Yamamoto; Junxiang Li; Hiroto Miwa; Koichi Noguchi; Yi Dai
Journal:  JCI Insight       Date:  2019-05-02

6.  Effects of prostaglandins E2 and F2 alpha on electromyogram of cat colon in vitro.

Authors:  J L Conklin; S Anuras
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

7.  Misoprostol is effective treatment for patients with severe chronic constipation.

Authors:  E E Soffer; A Metcalf; J Launspach
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

8.  Colonic postoperative inflammatory ileus in the rat.

Authors:  Andreas Türler; Beverly A Moore; Michael A Pezzone; Marcus Overhaus; Jörg C Kalff; Anthony J Bauer
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

9.  Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan.

Authors:  M Inoue; K Tajima; K Hirose; N Hamajima; T Takezaki; T Hirai; T Kato; Y Ohno
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

10.  Bowel movement frequency and risk of colorectal cancer in a large cohort study of Japanese men and women.

Authors:  M Kojima; K Wakai; S Tokudome; K Tamakoshi; H Toyoshima; Y Watanabe; N Hayakawa; K Suzuki; S Hashimoto; Y Ito; A Tamakoshi
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.